Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Testicular Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Testicular Seminoma (7
)
Testicular Seminoma (7
)
›
Associations
(22)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
etoposide IV
Sensitive: A1 - Approval
etoposide IV
Sensitive
:
A1
etoposide IV
Sensitive: A1 - Approval
etoposide IV
Sensitive
:
A1
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
ifosfamide
Sensitive: A1 - Approval
ifosfamide
Sensitive
:
A1
ifosfamide
Sensitive: A1 - Approval
ifosfamide
Sensitive
:
A1
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
TI-CE
Sensitive: A2 - Guideline
TI-CE
Sensitive
:
A2
TI-CE
Sensitive: A2 - Guideline
TI-CE
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
EP
Sensitive: A2 - Guideline
EP
Sensitive
:
A2
EP
Sensitive: A2 - Guideline
EP
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
VeIP
Sensitive: A2 - Guideline
VeIP
Sensitive
:
A2
VeIP
Sensitive: A2 - Guideline
VeIP
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
BEP
Sensitive: A2 - Guideline
BEP
Sensitive
:
A2
BEP
Sensitive: A2 - Guideline
BEP
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
VIP
Sensitive: A2 - Guideline
VIP
Sensitive
:
A2
VIP
Sensitive: A2 - Guideline
VIP
Sensitive
:
A2
TMB-H
Testicular Seminoma
TMB-H
Testicular Seminoma
TIP
Sensitive: A2 - Guideline
TIP
Sensitive
:
A2
TIP
Sensitive: A2 - Guideline
TIP
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
gemcitabine + paclitaxel
Sensitive: A2 - Guideline
gemcitabine + paclitaxel
Sensitive
:
A2
gemcitabine + paclitaxel
Sensitive: A2 - Guideline
gemcitabine + paclitaxel
Sensitive
:
A2
MSI-H/dMMR
Testicular Cancer
MSI-H/dMMR
Testicular Cancer
cemiplimab-rwlc
Sensitive: A2 - Guideline
cemiplimab-rwlc
Sensitive
:
A2
cemiplimab-rwlc
Sensitive: A2 - Guideline
cemiplimab-rwlc
Sensitive
:
A2
TMB-H
Testicular Cancer
TMB-H
Testicular Cancer
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
pembrolizumab
Sensitive: A2 - Guideline
pembrolizumab
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
etoposide oral
Sensitive: A2 - Guideline
etoposide oral
Sensitive
:
A2
etoposide oral
Sensitive: A2 - Guideline
etoposide oral
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
GemOx
Sensitive: A2 - Guideline
GemOx
Sensitive
:
A2
GemOx
Sensitive: A2 - Guideline
GemOx
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
TI-CE
Sensitive: A2 - Guideline
TI-CE
Sensitive
:
A2
TI-CE
Sensitive: A2 - Guideline
TI-CE
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
carboplatin + etoposide IV
Sensitive: A2 - Guideline
carboplatin + etoposide IV
Sensitive
:
A2
carboplatin + etoposide IV
Sensitive: A2 - Guideline
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
GemPOx
Sensitive: A2 - Guideline
GemPOx
Sensitive
:
A2
GemPOx
Sensitive: A2 - Guideline
GemPOx
Sensitive
:
A2
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
BNT211
Sensitive: B - Late Trials
BNT211
Sensitive
:
B
BNT211
Sensitive: B - Late Trials
BNT211
Sensitive
:
B
CLDN6 expression
Testicular Cancer
CLDN6 expression
Testicular Cancer
TORL-1-23
Sensitive: C3 – Early Trials
TORL-1-23
Sensitive
:
C3
TORL-1-23
Sensitive: C3 – Early Trials
TORL-1-23
Sensitive
:
C3
CHEK2 mutation
Testicular Cancer
CHEK2 mutation
Testicular Cancer
talazoparib
Sensitive: C4 – Case Studies
talazoparib
Sensitive
:
C4
talazoparib
Sensitive: C4 – Case Studies
talazoparib
Sensitive
:
C4
CLDN6 expression
Testicular Cancer
CLDN6 expression
Testicular Cancer
IMAB027-vcMMAE
Sensitive: D – Preclinical
IMAB027-vcMMAE
Sensitive
:
D
IMAB027-vcMMAE
Sensitive: D – Preclinical
IMAB027-vcMMAE
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login